Status: Phase 2
Entry Type: Unknown
Molecule Category: UNKNOWN

Indications

Mesh Heading Maximum Phase Reference
Diabetic Nephropathies; Kidney Diseases Phase 2 ClinicalTrials
Kidney Failure, Chronic Phase 2 ClinicalTrials
CONTENTS